Xylem (NYSE:XYL) Cut to “Neutral” at JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered shares of Xylem (NYSE:XYL) from an overweight rating to a neutral rating in a report released on Wednesday morning, MarketBeat.com reports. They currently have $90.00 price objective on the industrial products company’s stock, down from their previous price objective of $118.00.

A number of other equities research analysts have also recently commented on the stock. Wolfe Research started coverage on shares of Xylem in a research note on Tuesday, September 15th. They set a “peer perform” rating on the stock. UBS Group dropped their price target on shares of Xylem from $138.00 to $112.00 and set a “neutral” rating on the stock in a research report on Monday, October 5th. Barclays cut their price objective on shares of Xylem from $159.00 to $139.00 and set an “overweight” rating for the company in a report on Tuesday, October 13th. Jefferies Financial Group lifted their price target on Xylem from $145.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, August 24th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $150.00 price target (down from $158.00) on shares of Xylem in a report on Wednesday, October 14th. Nine analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $121.31.

Xylem Stock Up 1.8%

Shares of XYL opened at $92.41 on Wednesday. The company has a market capitalization of $21.19 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.51 and a beta of 1.00. Xylem has a 52 week low of $87.40 and a 52 week high of $152.43. The stock’s 50-day moving average price is $105.05 and its 200-day moving average price is $117.57. The company has a quick ratio of 1.24, a current ratio of 1.39 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a net margin of 11.94% and a return on equity of 12.06%. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. During the same quarter in the prior year, the business posted $1.37 earnings per share. The firm’s revenue was down 3.0% compared to the same quarter last year. On average, sell-side analysts predict that Xylem will post 5.45 EPS for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Thursday, August 27th. Xylem’s payout ratio is 40.95%.

Insider Activity at Xylem

In other Xylem news, Director D Koch purchased 11,000 shares of the firm’s stock in a transaction dated Thursday, October 29th. The shares were purchased at an average cost of $89.60 per share, with a total value of $985,600.00. Following the completion of the purchase, the director owned 12,247 shares in the company, valued at approximately $1,097,331.20. This represents a 882.12% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.32% of the stock is owned by company insiders.

Institutional Trading of Xylem

Several large investors have recently bought and sold shares of the business. State Street Corp grew its stake in shares of Xylem by 2.4% in the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock valued at $1,352,874,000 after buying an additional 270,972 shares in the last quarter. XXEC Inc. lifted its stake in Xylem by 477.9% during the 1st quarter. XXEC Inc. now owns 171,211 shares of the industrial products company’s stock worth $20,460,000 after acquiring an additional 141,586 shares in the last quarter. Perpetual Ltd lifted its stake in Xylem by 10.2% during the 3rd quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company’s stock worth $13,160,000 after acquiring an additional 11,993 shares in the last quarter. NFJ Investment Group LLC acquired a new position in Xylem during the 2nd quarter worth about $4,116,000. Finally, TD Waterhouse Canada Inc. boosted its holdings in Xylem by 1,922.6% during the 2nd quarter. TD Waterhouse Canada Inc. now owns 46,034 shares of the industrial products company’s stock valued at $5,400,000 after acquiring an additional 43,758 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Key Stories Impacting Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
• Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
• Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
• Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
• Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.